The Centers for Medicare & Medicaid Services May 12 released draft guidance for the third round of negotiations for the Medicare Drug Price Negotiation Program. The guidance includes policies ...

President Donald Trump incorrectly placed the blame for high prescription drug prices in the U.S. on foreign nations, making ...

Emphasizes that the United States aims to provide access to prescription drugs at lower costs for US patients and taxpayers, ...

In signing an executive order aimed at reducing U.S. drug prices, President Donald Trump said some prices would be cut in ...

If prescription savings are to be passed on to Americans not on Medicare, Congress likely would have to pass a law to enact ...

President Donald Trump has now been in office for more than 100 days, and investors certainly have a much more clear picture ...

For the first time in history, Medicare has the power to negotiate the price it pays for some of the costliest and most-used ...

To be clear, that concern was well-founded: High drug prices are one reason the U.S. has become a global leader in medical innovation. Some of the most important advancements in the field — from ...

More than 100 days into President Donald Trump’s second term, the administration has fallen into a pattern. Trump releases an ...

The president has signed an executive order stating that the US will institute a “most-favored-nation” policy, whereby the US will pay the same price for a drug as the nation that pays the lowest ...

Under the Medicare Drug Price Negotiation Program, the HHS secretary negotiates directly with manufacturers on the prices ...